• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾功能受损患者复发性中风风险增加:来自MICON国际合作项目个体患者数据的汇总分析结果

Increased risk of recurrent stroke in patients with impaired kidney function: results of a pooled analysis of individual patient data from the MICON international collaboration.

作者信息

Molad Jeremy, Miwa Kaori, Nash Philip S, Ambler Gareth, Best Jonathan, Wilson Duncan, Hallevi Hen, Fandler-Höfler Simon, Eppinger Sebastian, Du Houwei, Al-Shahi Salman Rustam, Jäger Hans R, Lip Gregory Y H, Goeldlin Martina B, Beyeler Morin, Bücke Philipp, El-Koussy Marwan, Mattle Heinrich Paul, Panos Leonidas D, van Dam-Nolen Dianne H K, Dubost Florian, Hendrikse Jeroen, Kooi M Eline, Mess Werner, Nederkoorn Paul J, Shiozawa Masayuki, Christ Nicolas, Bellut Maximilian, Gunkel Sarah, Karayiannis Christopher, Van Ly John, Singhal Shaloo, Slater Lee-Anne, Kim Young Dae, Song Tae-Jin, Lee Keon-Joo, Lim Jae-Sung, Hara Hideo, Nishihara Masashi, Tanaka Jun, Yoshikawa Masaaki, Demirelli Derya Selcuk, Tanriverdi Zeynep, Uysal Ender, Coutts Shelagh B, Chappell Francesca M, Makin Stephen, Mak Henry Ka-Fung, Teo Kay Cheong, Wong Debbie Y K, Hert Lisa, Kubacka Marta, Lyrer Philippe, Polymeris Alexandros A, Wagner Benjamin, Zietz Annaelle, Abrigo Jill M, Cheng Cyrus, Chu Winnie C W, Leung Thomas W H, Tsang Suk Fung, Yiu Brian, Seiffge David J, Fischer Urs, Jung Simon, Enzinger Christian, Gattringer Thomas, Bos Daniel, Toyoda Kazunori, Fluri Felix, Phan Thanh G, Srikanth Velandai, Heo Ji Hoe, Bae Hee-Joon, Yakushiji Yusuke, Orken Dilek Necioglu, Smith Eric E, Wardlaw Joanna M, Lau Kui Kai, Engelter Stefan T, Peters Nils, Soo Yannie, Wheeler David C, Simister Robert J, Bornstein Natan M, Werring David J, Ben Assayag Einor, Koga Masatoshi

机构信息

Department of Stroke & Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.

出版信息

J Neurol Neurosurg Psychiatry. 2025 Apr 24. doi: 10.1136/jnnp-2024-335110.

DOI:10.1136/jnnp-2024-335110
PMID:40274401
Abstract

BACKGROUND

Patients with chronic kidney disease are at increased risk of stroke and frequently have cerebral microbleeds. Whether such patients also encounter an increased risk of recurrent stroke has not been firmly established. We aimed to determine whether impaired kidney function is associated with the risk of recurrent stroke, and microbleed presence, distribution and severity.

METHODS

We used pooled data from the Microbleeds International Collaborate Network to investigate associations of impaired kidney function, defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m. Our primary outcome was a composite of recurrent ischaemic stroke (IS) and intracranial haemorrhage (ICrH). Secondary outcomes included: (1) individual components of the primary outcome; (2) modification of the primary outcome by microbleed presence or anticoagulant use and (3) microbleed presence, distribution and severity.

RESULTS

11 175 patients (mean age 70.7±12.6, 42% female) were included, of which 2815 (25.2%) had impaired kidney function. Compared with eGFR ≥60, eGFR <60 was associated with a higher risk of the primary outcome (adjusted HR, aHR 1.33 (95% CI 1.14 to 1.56), p<0.001) and higher rates of the recurrent IS (aHR 1.33 (95% CI 1.12 to 1.58)). Reduced eGFR was not associated with ICrH risk (aHR 1.07 (95% CI 0.70 to 1.60)). eGFR was also associated with microbleed presence (adjusted OR, aOR 1.14 (95% CI 1.03 to 1.26)) and severity (aOR 1.17 (95% CI 1.06 to 1.29)). Compared with having no microbleeds, eGFR was lower in those with strictly lobar microbleeds (adjusted mean difference (aMD) -2.10 mL/min/1.73 cm (95% CI -3.39 to -0.81)) and mixed microbleeds (aMD -2.42 (95% CI -3.70 to -1.15)), but not strictly deep microbleeds (aMD -0.67 (95% CI -1.85 to 0.51)).

CONCLUSIONS

In patients with IS or transient ischaemic attack, impaired kidney function was associated with a higher risk of recurrent stroke and higher microbleeds burden, compared with those with normal kidney function. Further research is needed to investigate potential additional measures for secondary prevention in this high-risk group.

摘要

背景

慢性肾脏病患者发生中风的风险增加,且经常出现脑微出血。此类患者复发性中风的风险是否也会增加尚未得到确凿证实。我们旨在确定肾功能受损是否与复发性中风的风险以及微出血的存在、分布和严重程度相关。

方法

我们使用了来自国际微出血协作网络的汇总数据,以研究肾功能受损(定义为估计肾小球滤过率(eGFR)<60 mL/min/1.73 m²)之间的关联。我们的主要结局是复发性缺血性中风(IS)和颅内出血(ICrH)的复合结局。次要结局包括:(1)主要结局的各个组成部分;(2)根据微出血的存在或抗凝剂的使用对主要结局进行修正;以及(3)微出血的存在、分布和严重程度。

结果

共纳入11175例患者(平均年龄70.7±12.6岁,42%为女性),其中2815例(25.2%)肾功能受损。与eGFR≥60相比,eGFR<60与主要结局的较高风险相关(调整后风险比,aHR 1.33(95%置信区间1.14至1.56),p<0.001)以及复发性IS的较高发生率(aHR 1.33(95%置信区间1.12至1.58))。eGFR降低与ICrH风险无关(aHR 1.07(95%置信区间0.70至1.60))。eGFR还与微出血的存在(调整后比值比,aOR 1.14(95%置信区间1.03至1.26))和严重程度(aOR 1.17(95%置信区间1.06至1.29))相关。与无微出血相比,严格叶性微出血患者的eGFR较低(调整后平均差值,aMD -2.10 mL/min/1.73 cm²(95%置信区间 -3.39至 -0.81)),混合性微出血患者的eGFR也较低(aMD -2.42(95%置信区间 -3.70至 -1.15)),但严格深部微出血患者的eGFR无明显差异(aMD -0.67(95%置信区间 -1.85至0.51))。

结论

在患有IS或短暂性脑缺血发作的患者中,与肾功能正常的患者相比,肾功能受损与复发性中风的较高风险和较高的微出血负担相关。需要进一步研究以探讨针对这一高危人群进行二级预防的潜在额外措施。

相似文献

1
Increased risk of recurrent stroke in patients with impaired kidney function: results of a pooled analysis of individual patient data from the MICON international collaboration.肾功能受损患者复发性中风风险增加:来自MICON国际合作项目个体患者数据的汇总分析结果
J Neurol Neurosurg Psychiatry. 2025 Apr 24. doi: 10.1136/jnnp-2024-335110.
2
Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds.他汀类药物治疗伴有脑微出血的缺血性脑卒中患者的二级预防。
Neurology. 2024 Apr 9;102(7):e209173. doi: 10.1212/WNL.0000000000209173. Epub 2024 Mar 12.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
5
Illicit drug use and cerebral microbleeds in patients with acute ischemic stroke and transient ischemic attack.急性缺血性中风和短暂性脑缺血发作患者的非法药物使用与脑微出血
Int J Stroke. 2025 Aug;20(7):874-882. doi: 10.1177/17474930251328524. Epub 2025 Mar 11.
6
Endovascular thrombectomy with versus without intravenous thrombolysis for acute ischaemic stroke.急性缺血性卒中血管内血栓切除术联合与不联合静脉溶栓治疗的比较
Cochrane Database Syst Rev. 2025 Apr 24;4(4):CD015721. doi: 10.1002/14651858.CD015721.pub2.
7
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在患有早期(1 至 3 期)非糖尿病慢性肾脏病的成人中的应用。
Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3.
8
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
9
BioImpedance Spectroscopy to maintain Renal Output: the BISTRO randomised controlled trial.生物电阻抗光谱法维持肾输出量:BISTRO随机对照试验
Health Technol Assess. 2025 Jul;29(32):1-23. doi: 10.3310/RHON2378.
10
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂用于患有早期(1至3期)非糖尿病慢性肾病的成人。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007751. doi: 10.1002/14651858.CD007751.pub2.

引用本文的文献

1
CD2AP at the junction of nephropathy and Alzheimer's disease.肾病与阿尔茨海默病交叉点上的CD2相关蛋白
Mol Neurodegener. 2025 Jun 4;20(1):63. doi: 10.1186/s13024-025-00852-x.

本文引用的文献

1
Histopathological Correlates of Lobar Microbleeds in False-Positive Cerebral Amyloid Angiopathy Cases.脑淀粉样血管病假阳性病例中微出血灶的组织病理学相关性
Ann Neurol. 2023 Nov;94(5):856-870. doi: 10.1002/ana.26761. Epub 2023 Sep 6.
2
Neuroimaging standards for research into small vessel disease-advances since 2013.神经影像学在小血管疾病研究中的标准——2013 年以来的进展。
Lancet Neurol. 2023 Jul;22(7):602-618. doi: 10.1016/S1474-4422(23)00131-X. Epub 2023 May 23.
3
Decreased Estimated Glomerular Filtration Rate and Proteinuria and Long-Term Outcomes After Ischemic Stroke: A Longitudinal Observational Cohort Study.
估算肾小球滤过率和蛋白尿降低与缺血性脑卒中后的长期结局:一项纵向观察性队列研究。
Stroke. 2023 May;54(5):1268-1277. doi: 10.1161/STROKEAHA.122.040958. Epub 2023 Apr 6.
4
The Association of Kidney Function with Plasma Amyloid-β Levels and Brain Amyloid Deposition.肾脏功能与血浆淀粉样蛋白-β水平和脑淀粉样蛋白沉积的关系。
J Alzheimers Dis. 2023;92(1):229-239. doi: 10.3233/JAD-220765.
5
Urinary Immunoglobulin G Is Associated with Deep and Infratentorial Cerebral Microbleeds in Stroke Patients.尿免疫球蛋白 G 与脑卒中患者的深部和幕下脑微出血相关。
Cerebrovasc Dis. 2023;52(4):417-426. doi: 10.1159/000527019. Epub 2022 Nov 8.
6
The new, race-free, Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) equation to estimate glomerular filtration rate: is it applicable in Europe? A position statement by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM).新的、无种族的慢性肾脏病流行病学合作组(CKD-EPI)方程估算肾小球滤过率:它在欧洲适用吗?欧洲临床化学和实验室医学联合会(EFLM)的立场声明。
Clin Chem Lab Med. 2022 Oct 24;61(1):44-47. doi: 10.1515/cclm-2022-0928. Print 2023 Jan 27.
7
What should European nephrology do with the new CKD-EPI equation?欧洲肾脏病学对于新的慢性肾脏病流行病学合作组(CKD-EPI)方程应作何举措?
Nephrol Dial Transplant. 2023 Jan 23;38(1):1-6. doi: 10.1093/ndt/gfac254.
8
Performance of creatinine-based equations to estimate glomerular filtration rate in White and Black populations in Europe, Brazil and Africa.基于肌酐的方程在欧洲、巴西和非洲白人群体及黑人群体中估算肾小球滤过率的性能。
Nephrol Dial Transplant. 2023 Jan 23;38(1):106-118. doi: 10.1093/ndt/gfac241.
9
Association of Chronic Kidney Disease With Risk of Intracerebral Hemorrhage.慢性肾脏病与脑出血风险的关联。
JAMA Neurol. 2022 Sep 1;79(9):911-918. doi: 10.1001/jamaneurol.2022.2299.
10
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper.房颤和静脉血栓栓塞症出血风险评估与管理:欧洲和亚太专家共识文件的执行摘要。
Thromb Haemost. 2022 Oct;122(10):1625-1652. doi: 10.1055/s-0042-1750385. Epub 2022 Jul 6.